MyFinsight
Home
Blog
About
Amneal Pharmaceuticals, Inc. (AMRX)
Amneal Pharmaceuticals, Inc. (AMRX)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$51,941K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Borrowings on revolving credit f...
Net income
Accounts payable, accrued expens...
Others
Negative Cash Flow Breakdown
Trade accounts receivable, net
Acquisition of intangible assets
Inventories
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income
69,614
78,000
49,573
18,132
Depreciation and amortization
47,800
43,191
49,227
54,073
Unrealized foreign currency loss (gain)
-2,280
-8,215
-1,153
-3,207
Amortization of debt issuance costs and discount
4,064
3,890
3,715
5,030
Reclassification of cash flow hedge
-2,910
-2,878
-2,942
-4,163
Loss on refinancing
0
-3,510
0
-31,365
Intangible asset impairment charges
-
-
0
22,784
Change in fair value of contingent consideration
-
-
0
-
Stock-based compensation
10,392
8,816
8,202
8,219
Inventory provision
31,604
13,353
26,636
20,894
Other operating charges and credits, net
-1,600
-1,486
-1,157
-1,321
Trade accounts receivable, net
169,778
-44,013
10,338
77,613
Inventories
69,191
54,959
20,180
30,807
Prepaid expenses, other current assets and other assets
10,750
13,400
-1,010
10,158
Related party receivables
-81
56
-817
-278
Accounts payable, accrued expenses and other liabilities
66,660
-124,578
18,577
69,748
Related party payables
-8,530
-41,102
-2,176
-2,186
Net cash (used in) provided by operating activities
-21,244
-26,743
130,315
118,450
Purchases of property, plant and equipment
30,697
8,175
21,773
12,298
Acquisition of intangible assets
77,150
7,850
3,000
7,414
Deposits for future acquisition of property, plant and equipment
14,895
5,685
21,396
2,752
Proceeds from sale of property, plant and equipment
0
-1,379
-
0
Proceeds from sale of property, plant, equipment and other
-
-
2,094
-
Proceeds from sale of subsidiary
-
-
0
0
Net cash used in investing activities
-122,742
-21,710
-45,454
-22,464
Proceeds from issuance of debt
-
-
-
2,694,750
Payments of principal on debt, revolving credit facilities, financing leases and other
6,185
140,842
-5,616,892
2,554,308
Proceeds from issuance of debt
0
134,673
2,694,750
-
Payments of deferred financing, refinancing costs and debt extinguishment costs
-
-
74,973
-
Payments of deferred financing and refinancing costs
0
-72,991
-
73,228
Borrowings on revolving credit facilities
100,000
0
0
0
Proceeds from exercise of stock options
42
38
553
653
Employee payroll tax withholding on restricted stock unit and performance stock unit vesting
176
44,305
321
129
Tax and other distributions to non-controlling interests
13,920
7,147
5,023
38,825
Payment of principal on notes payable - related party
-
-
0
0
Proceeds from alliance party
0
510
795
5,572
Acquisition of non-controlling interest
400
-
-
-
Net cash provided by (used in) financing activities
79,361
-59,055
-10,120
59,443
Effect of foreign exchange rate on cash
-164
-1,023
-209
-694
Net decrease in cash, cash equivalents, and restricted cash
-64,789
-108,531
74,532
154,735
Cash, cash equivalents, and restricted cash - beginning of period
204,408
312,939
238,407
118,420
Cash, cash equivalents, and restricted cash - end of period
139,619
-
-
-
Cash and cash equivalents - end of period
127,637
-
-
-
Restricted cash - end of period
8,643
-
-
-
Long-term restricted cash included in other assets - end of period
3,339
-
-
-
Cash, cash equivalents, and restricted cash - end of period
139,619
204,408
312,939
238,407
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Borrowings on revolving
credit facilities
$100,000K
(-54.13%↓ Y/Y)
Proceeds from exercise of
stock options
$42K
(-94.43%↓ Y/Y)
Net cash provided by
(used in) financing...
$79,361K
(198.15%↑ Y/Y)
Canceled cashflow
$20,681K
Net decrease in
cash, cash...
-$64,789K
(-86.45%↓ Y/Y)
Canceled cashflow
$79,361K
Net income
$69,614K
(15.58%↑ Y/Y)
Accounts payable,
accrued expenses and...
$66,660K
(199.49%↑ Y/Y)
Depreciation and
amortization
$47,800K
(-60.26%↓ Y/Y)
Inventory provision
$31,604K
(-17.77%↓ Y/Y)
Stock-based compensation
$10,392K
(-33.09%↓ Y/Y)
Amortization of debt issuance
costs and discount
$4,064K
(-70.31%↓ Y/Y)
Reclassification of cash flow
hedge
-$2,910K
(-149.52%↓ Y/Y)
Unrealized foreign
currency loss (gain)
-$2,280K
(-119.30%↓ Y/Y)
Other operating
charges and credits, net
-$1,600K
(29.02%↑ Y/Y)
Related party
receivables
-$81K
(-107.31%↓ Y/Y)
Tax and other
distributions to...
$13,920K
(-44.23%↓ Y/Y)
Payments of principal on
debt, revolving...
$6,185K
(-97.54%↓ Y/Y)
Acquisition of
non-controlling interest
$400K
Employee payroll tax
withholding on restricted...
$176K
(-99.19%↓ Y/Y)
Net cash used in
investing activities
-$122,742K
(-176.79%↓ Y/Y)
Net cash (used in)
provided by operating...
-$21,244K
(-123.29%↓ Y/Y)
Effect of foreign
exchange rate on cash
-$164K
(78.89%↑ Y/Y)
Canceled cashflow
$237,005K
Acquisition of intangible
assets
$77,150K
(1412.75%↑ Y/Y)
Purchases of property,
plant and equipment
$30,697K
(-14.71%↓ Y/Y)
Deposits for future
acquisition of property,...
$14,895K
(221.57%↑ Y/Y)
Trade accounts
receivable, net
$169,778K
(420.55%↑ Y/Y)
Inventories
$69,191K
(91.99%↑ Y/Y)
Prepaid expenses, other
current assets and other...
$10,750K
(7.34%↑ Y/Y)
Related party payables
-$8,530K
(-261.16%↓ Y/Y)
Buy us a coffee